Focus on kidney cancer - PubMed (original) (raw)

Review

Focus on kidney cancer

W Marston Linehan et al. Cancer Cell. 2004 Sep.

Free article

Erratum in

• Cancer Cell. 2004 Oct;6(4):423

No abstract available

PubMed Disclaimer

Similar articles

• Analysis of two single nucleotide polymorphisms and loss of heterozygosity detection in the VHL gene in Chinese patients with sporadic renal cell carcinoma.
  Liu N, Gong K, Na X, Wu G, Na YQ. Liu N, et al. Chin Med J (Engl). 2005 Aug 5;118(15):1291-4. Chin Med J (Engl). 2005. PMID: 16117884 No abstract available.
• [Genetic backgrounds of renal cell carcinoma].
  Oya M. Oya M. Nihon Rinsho. 2006 Feb;64 Suppl 2:593-6. Nihon Rinsho. 2006. PMID: 16523961 Review. Japanese. No abstract available.
• Treatment of renal-cell cancer by transplantation of allogeneic stem cells.
  Burk RD. Burk RD. N Engl J Med. 2001 Jan 11;344(2):137; author reply 138. N Engl J Med. 2001. PMID: 11188410 No abstract available.
• The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma.
  Sufan RI, Jewett MA, Ohh M. Sufan RI, et al. Am J Physiol Renal Physiol. 2004 Jul;287(1):F1-6. doi: 10.1152/ajprenal.00424.2003. Am J Physiol Renal Physiol. 2004. PMID: 15180922 Review.
• Germline and somatic mutations in von Hippel-Lindau disease gene and its significance in the development of kidney cancer.
  Shuin T, Kondo K, Ashida S, Okuda H, Yoshida M, Kanno H, Yao M. Shuin T, et al. Contrib Nephrol. 1999;128:1-10. doi: 10.1159/000059976. Contrib Nephrol. 1999. PMID: 10597373 Review. No abstract available.

Cited by

• Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma.
  Zhong M, De Angelo P, Osborne L, Keane-Tarchichi M, Goldfischer M, Edelmann L, Yang Y, Linehan WM, Merino MJ, Aisner S, Hameed M. Zhong M, et al. Am J Surg Pathol. 2010 Jun;34(6):757-66. doi: 10.1097/PAS.0b013e3181dd577e. Am J Surg Pathol. 2010. PMID: 20421778 Free PMC article.
• FoxO transcription factors promote AKT Ser473 phosphorylation and renal tumor growth in response to pharmacologic inhibition of the PI3K-AKT pathway.
  Lin A, Piao HL, Zhuang L, Sarbassov dos D, Ma L, Gan B. Lin A, et al. Cancer Res. 2014 Mar 15;74(6):1682-93. doi: 10.1158/0008-5472.CAN-13-1729. Epub 2014 Jan 21. Cancer Res. 2014. PMID: 24448243 Free PMC article.
• Hereditary kidney cancer: unique opportunity for disease-based therapy.
  Linehan WM, Pinto PA, Bratslavsky G, Pfaffenroth E, Merino M, Vocke CD, Toro JR, Bottaro D, Neckers L, Schmidt LS, Srinivasan R. Linehan WM, et al. Cancer. 2009 May 15;115(10 Suppl):2252-61. doi: 10.1002/cncr.24230. Cancer. 2009. PMID: 19402075 Free PMC article. Review.
• Genetic basis of bilateral renal cancer: implications for evaluation and management.
  Linehan WM. Linehan WM. J Clin Oncol. 2009 Aug 10;27(23):3731-3. doi: 10.1200/JCO.2009.23.0045. Epub 2009 Jul 13. J Clin Oncol. 2009. PMID: 19597019 Free PMC article. No abstract available.
• Tubulocystic renal cell carcinoma: is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases.
  Steiner P, Hora M, Stehlik J, Martinek P, Vanecek T, Petersson F, Michal M, Korabecna M, Travnicek I, Hes O. Steiner P, et al. Virchows Arch. 2013 Feb;462(2):183-92. doi: 10.1007/s00428-012-1367-z. Epub 2013 Jan 8. Virchows Arch. 2013. PMID: 23296808

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information